Recruitment of Director CMC

As a vital step in strengthening the organisation Respiratorius is pleased to have completed the recruitment of a Director CMC (Chemistry, Manufacturing, and Control).

PhD Carl-Magnus Andersson has extensive experience from drug discovery and development and has held senior positions within a number of pharma and biotech companies, including AstraDraco, Acadia pharmaceuticals, and KaroBio, where he has been responsible for the chemical and pharmaceutical sciences and also intellectual property strategies.

Carl-Magnus Andersson is associate professor of pharmaceutical chemistry and has co-authored more than 100 scientific papers and patent applications.

Johan Drott

President Respiratorius AB

+46 709-22 41 40

johan.drott@respiratorius.com

Respiratorius AB (publ) is developing drug candidates with the goal to launch drugs for common diseases cancer, chronic obstructive pulmonary disease (COPD) and severe asthma. In addition, the project portfolio is a project for improved diagnosis of certain cardiovascular diseases.